{"schema_version":"secwatch.filing_event.v1","accession":"0001728117-26-000077","form_type":"8-K","ticker":"GOSS","cik":"0001728117","company_name":"Gossamer Bio, Inc.","filed_at":"2026-08-21T12:01:10+00:00","discovered_at":"2026-08-21T12:05:00.273850+00:00","generated_at":"2026-08-21T12:05:07.548084+00:00","sec_items":["1.01","3.02","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Gossamer Bio raises $25M initial private placement, up to $225M more tied to FDA milestones","bullets":["Initial closing expected Aug 24, 2026: ~$25M gross from pre-funded warrants at $0.1399/share.","Second closing of ~$125M upon FDA acceptance of NDA for seralutinib in PAH; FDA Approval Warrants add ~$100M.","Proceeds to fund clinical development and commercialization of seralutinib in PAH and PH-ILD.","Warrants exercisable for preferred stock pre-stockholder approval, then common stock; conversion prices $0.14 and $0.187.","Company lock-up until FDA approval warrants exercised or Dec 31, 2026 if second closing not met."],"urls":{"canonical":"https://secwatch.observer/filing/0001728117-26-000077","json":"https://secwatch.observer/filing/0001728117-26-000077.json","markdown":"https://secwatch.observer/filing/0001728117-26-000077.md","text":"https://secwatch.observer/filing/0001728117-26-000077.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000077/0001728117-26-000077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000077/goss-20260820.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-21T12:05:07.548084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}